NYSE$CORBF
Global Cord Blood Corp · Q4 2013 earnings
Q4 2013 earnings · · Investor relations
Headline financials
Revenue & EPS history
Global Cord Blood · Revenue · Quarterly
$526M
Q4 2013+3,220.6%vs Q4 2012
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 15 quarterly earnings reports
-0.3%
Avg return
Earnings day
+0.2%
Avg return
5 days after
+1.1%
Avg return
30 days after
13%
2 / 15 earnings
Positive
+3.7%
Q2 2021
Best reaction
-2.4%
Q4 2022
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2023 | +0.0% | +0.0% | +0.0% | |
| Q4 2022 | -2.4% | -7.1% | +0.8% | |
| Q3 2022 | -0.2% | +8.3% | -6.7% | |
| Q2 2022 | -0.2% | +0.2% | +4.2% | |
| Q4 2021 | +0.0% | +7.2% | +0.4% | |
| Q1 2022 | -2.4% | -1.5% | -10.8% | |
| Q2 2021 | +3.7% | +1.6% | +7.6% | |
| Q4 2020 | -0.9% | +1.8% | +5.6% | |
| Q2 2020 | -0.2% | -0.9% | +10.0% | |
| Q4 2019 | -0.2% | -6.6% | -2.1% | |
| Q2 2019 | -0.3% | -0.7% | +4.5% | |
| Q4 2018 | -0.4% | -6.7% | -16.1% | |
| Q2 2018 | -1.7% | -2.8% | -10.9% | |
| Q4 2017 | +1.1% | +11.7% | +32.0% | |
| Q4 2016 | -0.2% | -1.3% | -2.4% | |
| Q2 2016 | — | — | — | |
| Q4 2015 | — | — | — | |
| Q2 2015 | — | — | — | |
| Q4 2014 | — | — | — | |
| Q2 2014 | — | — | — | |
| Q1 2014 | — | — | — | |
| Q4 2010 | — | — | — | |
| Q4 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2012 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — | |
| Q4 2011 | — | — | — | |
| Q2 2011 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro